JAGX

Jaguar Health Stock Price

1.495
-0.025 (-1.64%)
Upgrade to Real-Time
Regular Market
1.495

Low
0.185

52 Week Range

High
4.4696

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Jaguar Health Inc JAGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.025 -1.64% 1.495 11:35:16
Open Price Low Price High Price Close Price Prev Close
1.51 1.45 1.51 1.52
Bid Price Ask Price Spread News
1.49 1.50 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,764 1,061,166 $ 1.48 $ 1,568,830 - 0.185 - 4.4696
Last Trade Time Type Quantity Stock Price Currency
11:35:45 1 $ 1.495 USD

Period:

Draw Mode:

Jaguar Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 205.29M 137.32M 137.12M $ 9.39M $ - -1.18 -2.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.32M 0.70%

more financials information »

Jaguar Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JAGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.621.621.411.502,650,347-0.125-7.72%
1 Month1.581.721.261.515,444,842-0.085-5.38%
3 Months1.302.281.10041.6710,250,7640.19515.0%
6 Months3.343.581.10042.0111,197,807-1.85-55.24%
1 Year0.684.46960.1851.6321,523,6850.815119.85%
3 Years69.93175.000.1854.658,709,392-68.44-97.86%
5 Years120.40224.000.1857.186,142,649-118.91-98.76%

Jaguar Health Description

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.


Your Recent History
NASDAQ
JAGX
Jaguar Hea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.